Log in to save to my catalogue

T cell assays differentiate clinical and subclinical SARS-CoV-2 infections from cross-reactive antiv...

T cell assays differentiate clinical and subclinical SARS-CoV-2 infections from cross-reactive antiv...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_316bcccee68f41c8b075256474e98d3e

T cell assays differentiate clinical and subclinical SARS-CoV-2 infections from cross-reactive antiviral responses

About this item

Full title

T cell assays differentiate clinical and subclinical SARS-CoV-2 infections from cross-reactive antiviral responses

Publisher

London: Nature Publishing Group UK

Journal title

Nature communications, 2021-04, Vol.12 (1), p.2055-14, Article 2055

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Identification of protective T cell responses against SARS-CoV-2 requires distinguishing people infected with SARS-CoV-2 from those with cross-reactive immunity to other coronaviruses. Here we show a range of T cell assays that differentially capture immune function to characterise SARS-CoV-2 responses. Strong ex vivo ELISpot and proliferation resp...

Alternative Titles

Full title

T cell assays differentiate clinical and subclinical SARS-CoV-2 infections from cross-reactive antiviral responses

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_316bcccee68f41c8b075256474e98d3e

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_316bcccee68f41c8b075256474e98d3e

Other Identifiers

ISSN

2041-1723

E-ISSN

2041-1723

DOI

10.1038/s41467-021-21856-3

How to access this item